Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1993; 22:955-962
© 1993 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uretsky, B.
Right arrow Articles by Jolly, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uretsky, B.
Right arrow Articles by Jolly, M.

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

BF Uretsky, JB Young, FE Shahidi, LG Yellen, MC Harrison, and MK Jolly

Presbyterian University Hospital, Pittsburgh, Pennsylvania 15213.

OBJECTIVES. The purpose of this study was to determine whether digoxin is effective in patients with chronic, stable mild to moderate heart failure. BACKGROUND. Digoxin has been a traditional therapy in heart failure, but methodologic limitations in earlier studies have prevented definitive conclusions regarding its efficacy. METHODS. Withdrawal of digoxin (placebo group, n = 46) or its continuation (digoxin group, n = 42) was performed in a prospective, randomized, double-blind, placebo-controlled multicenter trial of patients with chronic, stable mild to moderate heart failure secondary to left ventricular systolic dysfunction who had normal sinus rhythm and were receiving long-term treatment with diuretic drugs and digoxin. RESULTS. Patients withdrawn from digoxin therapy showed worsened maximal exercise capacity (median change in exercise time -96 s) compared with that of patients who continued to receive digoxin (change in exercise time +4.5 s) (p = 0.003). Patients withdrawn from digoxin therapy showed an increased incidence of treatment failures (p = 0.039) (39%, digoxin withdrawal group vs. 19%, digoxin maintenance group) and a decreased time to treatment failure (p = 0.037). In addition, patients who continued to receive digoxin had a lower body weight (p = 0.044) and heart rate (p = 0.003) and a higher left ventricular ejection fraction (p = 0.016). CONCLUSIONS. These data provide strong evidence of the clinical efficacy of digoxin in patients with normal sinus rhythm and mild to moderate chronic heart failure secondary to systolic dysfunction who are treated with diuretics.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al.
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
J. Am. Coll. Cardiol., April 14, 2009; 53(15): e1 - e90.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, M. A. Silver, et al.
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1343 - 1382.
[Full Text] [PDF]


Home page
CirculationHome page
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, et al.
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
Circulation, April 14, 2009; 119(14): 1977 - 2016.
[Full Text] [PDF]


Home page
CirculationHome page
2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al.
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
Circulation, April 14, 2009; 119(14): e391 - e479.
[Full Text] [PDF]


Home page
Circ Heart FailHome page
J. G.F. Cleland and D. Cullington
Digoxin: Quo Vadis?
Circ Heart Fail, March 1, 2009; 2(2): 81 - 85.
[Full Text] [PDF]


Home page
Circ Heart FailHome page
V. V. Georgiopoulou, A. P. Kalogeropoulos, G. Giamouzis, S. A. Agha, M. A. Rashad, S. Waheed, S. Laskar, A. L. Smith, and J. Butler
Digoxin Therapy Does Not Improve Outcomes in Patients With Advanced Heart Failure on Contemporary Medical Therapy
Circ Heart Fail, March 1, 2009; 2(2): 90 - 97.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. J. Ratain, T. Eisen, W. M. Stadler, K. T. Flaherty, S. B. Kaye, G. L. Rosner, M. Gore, A. A. Desai, A. Patnaik, H. Q. Xiong, et al.
Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma
J. Clin. Oncol., June 1, 2006; 24(16): 2505 - 2512.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Gheorghiade, D. J. van Veldhuisen, and W. S. Colucci
Contemporary Use of Digoxin in the Management of Cardiovascular Disorders
Circulation, May 30, 2006; 113(21): 2556 - 2564.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. Ahmed, M. W. Rich, T. E. Love, D. M. Lloyd-Jones, I. B. Aban, W. S. Colucci, K. F. Adams, and M. Gheorghiade
Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial
Eur. Heart J., January 2, 2006; 27(2): 178 - 186.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. B. Young
Whither Withering's Legacy?: Digoxin's Role in Our Contemporary Pharmacopeia for Heart Failure
J. Am. Coll. Cardiol., August 2, 2005; 46(3): 505 - 507.
[Full Text] [PDF]


Home page
Eur Heart JHome page
L. G. Olsson, K. Swedberg, A. L. Clark, K. K. Witte, and J. G.F. Cleland
Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review
Eur. Heart J., April 2, 2005; 26(8): 778 - 793.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
P. C. Burger and H. B.-L. Rocca
Pharmacotherapy of Congestive Heart Failure in Elderly Patients
Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2005; 10(2): 85 - 94.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
A. T. Yan, R. T. Yan, and P. P. Liu
Narrative Review: Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials
Ann Intern Med, January 18, 2005; 142(2): 132 - 145.
[Abstract] [Full Text] [PDF]


Home page
Fam PractHome page
W. E Cayley Jr
Digoxin in chronic heart failure
Fam. Pract., August 1, 2004; 21(4): 469 - 472.
[Full Text] [PDF]


Home page
CirculationHome page
S. H. Rahimtoola
Digitalis Therapy for Patients in Clinical Heart Failure
Circulation, June 22, 2004; 109(24): 2942 - 2946.
[Full Text] [PDF]


Home page
CirculationHome page
M. Gheorghiade, K. F. Adams Jr, and W. S. Colucci
Digoxin in the Management of Cardiovascular Disorders
Circulation, June 22, 2004; 109(24): 2959 - 2964.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
D. S. Chutka, P. Y. Takahashi, and R. W. Hoel
Inappropriate Medications for Elderly Patients
Mayo Clin. Proc., January 1, 2004; 79(1): 122 - 139.
[Abstract] [PDF]


Home page
Postgrad. Med. J.Home page
D B McKenzie and A J Cowley
Drug therapy in chronic heart failure
Postgrad. Med. J., November 1, 2003; 79(937): 634 - 642.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. C. Petrie
It cannot be cardiac failure because the heart is not enlarged on the chest X-ray
Eur J Heart Fail, March 1, 2003; 5(2): 117 - 119.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Radzewitz, E. Miche, G. Herrmann, M. Nowak, U. Montanus, U. Adam, Y. Stockmann, and M. Barth
Exercise and muscle strength training and their effect on quality of life in patients with chronic heart failure
Eur J Heart Fail, October 1, 2002; 4(5): 627 - 634.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K Kjeldsen, A Norgaard, and M Gheorghiade
Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure
Cardiovasc Res, September 1, 2002; 55(4): 710 - 713.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
B Swynghedauw and D Charlemagne
What is wrong with positive inotropic drugs? Lessons from basic science and clinical trials
Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D43 - D49.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
K. F. Adams Jr, M. Gheorghiade, B. F. Uretsky, J. H. Patterson, T. A. Schwartz, and J. B. Young
Clinical benefits of low serum digoxin concentrations in heart failure
J. Am. Coll. Cardiol., March 20, 2002; 39(6): 946 - 953.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. J. van Veldhuisen
Low-dose digoxin in patients with heart failure: Less toxic and at least as effective?
J. Am. Coll. Cardiol., March 20, 2002; 39(6): 954 - 956.
[Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
A. Ahmed, R. M. Allman, and J. F. DeLong
Inappropriate Use of Digoxin in Older Hospitalized Heart Failure Patients
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M138 - 143.
[Abstract] [Full Text]


Home page
Eur Heart JHome page
M.C. Petrie, C. Berry, S. Stewart, and J.J.V. McMurray
Failing ageing hearts
Eur. Heart J., November 1, 2001; 22(21): 1978 - 1990.
[PDF]


Home page
Br Med BullHome page
J. G F Cleland, J. John, J. Dhawan, and A. Clark
What is the optimal medical management of ischaemic heart failure?
Br. Med. Bull., October 1, 2001; 59(1): 135 - 158.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
C. A. Hassapoyannes, B. M. Easterling, K. Chavda, K. K. Chavda, M. R. Movahed, and G. W. Welch
The effect of chronic digitalization on pump function in systolic heart failure
Eur J Heart Fail, October 1, 2001; 3(5): 593 - 599.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. W. Rich, F. McSherry, W. O. Williford, S. Yusuf, and for the Digitalis Investigation Group
Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 806 - 813.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. J. Ratain, W. M. Stadler, E. L. Korn, S. G. Arbuck, J. M. Pluda, R. Simon, R. S. Kaplan, and M. C. Christian
Clinical Trial Designs for Cytostatic Agents
J. Clin. Oncol., June 15, 2001; 19(12): 3154 - 3155.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C Opasich, G.D Pinna, A Mazza, O Febo, R Riccardi, P.G Riccardi, S Capomolla, G Forni, F Cobelli, and L Tavazzi
Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?
Eur. Heart J., March 2, 2001; 22(6): 488 - 496.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. Gomberg-Maitland, D. A. Baran, and V. Fuster
Treatment of Congestive Heart Failure: Guidelines for the Primary Care Physician and the Heart Failure Specialist
Arch Intern Med, February 12, 2001; 161(3): 342 - 352.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. W. Stevenson and R. L. Kormos
Mechanical cardiac support 2000: current applications and future trial design: June 15-16, 2000 Bethesda, Maryland
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 340 - 370.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
C. J.F. Holubarsch, W. S. Colucci, T. Meinertz, W. Gaus, and M. Tendera
Survival and Prognosis: Investigation of Crataegus Extract WS 1442 in congestive heart failure (SPICE) -- rationale, study design and study protocol
Eur J Heart Fail, December 1, 2000; 2(4): 431 - 437.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
E. Lonn and R. McKelvie
Regular review: Drug treatment in heart failure
BMJ, April 29, 2000; 320(7243): 1188 - 1192.
[Full Text]


Home page
CirculationHome page
H. M. Krumholz, D. W. Baker, C. M. Ashton, S. B. Dunbar, G. C. Friesinger, E. P. Havranek, M. A. Hlatky, M. Konstam, D. L. Ordin, I. L. Pina, et al.
Evaluating Quality of Care for Patients With Heart Failure
Circulation, March 28, 2000; 101 (12): e122 - e140.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
M. W. Rich and R. F. Nease
Cost-effectiveness Analysis in Clinical Practice: The Case of Heart Failure
Arch Intern Med, August 9, 1999; 159(15): 1690 - 1700.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. Guyatt
A 75-Year-Old Man With Congestive Heart Failure
JAMA, June 23, 1999; 281(24): 2321 - 2328.
[Full Text] [PDF]


Home page
CirculationHome page
M. C. Petrie, N. F. Dawson, D. R. Murdoch, A. P. Davie, and J. J. V. McMurray
Failure of Women's Hearts
Circulation, May 4, 1999; 99(17): 2334 - 2341.
[Full Text] [PDF]


Home page
CirculationHome page
P. J. Hauptman and R. A. Kelly
Digitalis
Circulation, March 9, 1999; 99(9): 1265 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. M. Williamson, K. A. Thrasher, K. B. Fulton, N. M. A. LaPointe, G. D. Dunham, A. A. Cooper, P. S. Barrett, and J. H. Patterson
Digoxin Toxicity: An Evaluation in Current Clinical Practice
Arch Intern Med, December 1, 1998; 158(22): 2444 - 2449.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. B. Young, M. Gheorghiade, B. F. Uretsky, J. H. Patterson, and K. F. Adams Jr.
Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials
J. Am. Coll. Cardiol., September 1, 1998; 32(3): 686 - 692.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
W. T. Abraham
Pharmacologic Management of Chronic Heart Failure: A Review
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 168 - 190.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
T. A Schmidt and K. Kjeldsen
Human myocardial Na,K-ATPase -- quantification, regulation and relation to Ca
Cardiovasc Res, February 1, 1998; 37(2): 335 - 345.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. T. Sullebarger, P. M. D'Ambra, L. C. Clark, L. Thanikarry, and H. L. Fontanet
Effect of Digoxin on Ventricular Remodeling and Responsiveness of {beta}-Adrenoceptors in Chronic Volume Overload
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(4): 281 - 290.
[Abstract] [PDF]


Home page
HeartHome page
K Pardaens, J Van Cleemput, J Vanhaecke, and R H Fagard
Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients
Heart, December 1, 1997; 78(6): 564 - 568.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Matsumori, K. Ono, R. Nishio, H. Igata, B Pharm, T. Shioi, S. Matsui, Y. Furukawa, A. Iwasaki, Y. Nose, et al.
Modulation of Cytokine Production and Protection Against Lethal Endotoxemia by the Cardiac Glycoside Ouabain
Circulation, September 2, 1997; 96(5): 1501 - 1506.
[Abstract] [Full Text]


Home page
NEJMHome page
The Digitalis Investigation Group
The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure
N. Engl. J. Med., February 20, 1997; 336(8): 525 - 533.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. Packer
End of the Oldest Controversy in Medicine -- Are We Ready to Conclude the Debate on Digitalis?
N. Engl. J. Med., February 20, 1997; 336(8): 575 - 576.
[Full Text]


Home page
J CARDIOVASC PHARMACOL THERHome page
K. Ogunyankin and B. N. Singh
Reflections on Recent Clinical Trials in Patients With Heart Failure and Those With Reduced Ventricular Function
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(3): 147 - 152.
[PDF]


Home page
CirculationHome page
M. R. Costanzo, S. Augustine, R. Bourge, M. Bristow, J. B. O'Connell, D. Driscoll, and E. Rose
Selection and Treatment of Candidates for Heart Transplantation : A Statement for Health Professionals From the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association
Circulation, December 15, 1995; 92(12): 3593 - 3612.
[Abstract] [Full Text]


Home page
CirculationHome page
COMMITTEE MEMBERS, J. F. WILLIAMS Jr, M. R. BRISTOW, M. B. FOWLER, G. S. FRANCIS, A. GARSON Jr, B. J. GERSH, D. F. HAMMER, M. A. HLATKY, C. V. LEIER, et al.
Guidelines for the Evaluation and Management of Heart Failure : Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)
Circulation, November 1, 1995; 92(9): 2764 - 2784.
[Full Text]


Home page
CirculationHome page
M. Gheorghiade, V. B. Hall, G. Jacobsen, M. Alam, H. Rosman, and S. Goldstein
Effects of Increasing Maintenance Dose of Digoxin on Left Ventricular Function and Neurohormones in Patients With Chronic Heart Failure Treated With Diuretics and Angiotensin-Converting Enzyme Inhibitors
Circulation, October 1, 1995; 92(7): 1801 - 1807.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Zoneraich and D. H. Spodick
Bedside Science Reduces Laboratory Art : Appropriate Use of Physical Findings to Reduce Reliance on Sophisticated and Expensive Methods
Circulation, April 1, 1995; 91(7): 2089 - 2092.
[Full Text]


Home page
BMJHome page
J. McMurray and A. Rankin
Recent Advances: Cardiology II: Treatment of heart failure and atrial fibrillation and arrhythmias
BMJ, December 17, 1994; 309(6969): 1631 - 1635.
[Full Text]


Home page
JAMAHome page
W. W. Parmley
Clinical Practice Guidelines: Does the Cookbook Have Enough Recipes?
JAMA, November 2, 1994; 272(17): 1374 - 1375.
[Abstract] [PDF]


Home page
JWatch GeneralHome page
MORE EVIDENCE THAT DIGOXIN IS BENEFICIAL FOR CHF
Journal Watch (General), October 8, 1993; 1993(1008): 4 - 4.
[Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement